TGFBR1 and pulmonary fibrosis: Among them, miR-18a-5p and miR-153 directly target TGF-βRII, whereas miR-1344 can not only target TGF-βRII but also TGF-βRI (ALK5), which showed anti-fibrotic effects in lung fibrosis models (Liang et al., 2015; Stolzenburg et al., 2016; Zhang et al., 2017).